Table of Contents Author Guidelines Submit a Manuscript
Journal of Chemistry
Volume 2013, Article ID 612082, 4 pages
http://dx.doi.org/10.1155/2013/612082
Research Article

Development and Validation of a RP-HPLC Method for Determination of Nimodipine in Sustained Release Tablets

School of Pharmacy, Xinxiang Medical University, Xinxiang 453003, China

Received 5 May 2013; Accepted 11 July 2013

Academic Editor: Irene Panderi

Copyright © 2013 Xiaojun Shang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Nimodipine, http://en.wikipedia.org/wiki/Nimodipine.
  2. P. Barmpalexis, K. Kachrimanis, and E. Georgarakis, “Solid dispersions in the development of a nimodipine floating tablet formulation and optimization by artificial neural networks and genetic programming,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 77, no. 1, pp. 122–131, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. A. A. Kale and V. B. Patravale, “Design and evaluation of self-emulsifying drug delivery systems (SEDDS) of nimodipine,” AAPS PharmSciTech, vol. 9, no. 1, pp. 191–196, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. T. T. Guan, Y. Q. Miao, L. S. Xu et al., “Injectable nimodipine-loaded nanoliposomes: preparation, lyophilization and characteristics,” International Journal of Pharmaceutics, vol. 410, no. 1-2, pp. 180–187, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. Z. Sun, Y. Rui, Z. Wenliang, and X. Tang, “Nimodipine semi-solid capsules containing solid dispersion for improving dissolution,” International Journal of Pharmaceutics, vol. 359, no. 1-2, pp. 144–149, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. S. A. E.-S. Fahmy, J. M. Christensen, and J. W. Ayres, “Development of novel spray coated soft elastic gelatin capsule sustained release formulations of nifedipine,” Drug Development and Industrial Pharmacy, vol. 35, no. 8, pp. 1009–1021, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Charman and W. Charman, “Oral modified-release delivery systems,” in Modified-Release Drug Delivery Technology, M. Rathbone, J. Hadgraft, and M. Roberts, Eds., Marcel Dekker, New York, NY, USA, 2003. View at Google Scholar
  8. P. Barmpalexis, F. I. Kanaze, and E. Georgarakis, “Developing and optimizing a validated isocratic reversed-phase high-performance liquid chromatography separation of nimodipine and impurities in tablets using experimental design methodology,” Journal of Pharmaceutical and Biomedical Analysis, vol. 49, no. 5, pp. 1192–1202, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. F. Qin, Y. Ma, Y. Wang, L. Chen, D. Wang, and F. Li, “Determination of nimodipine in human plasma by ultra performance liquid chromatography-tandem mass spectrometry and pharmacokinetic application,” Journal of Pharmaceutical and Biomedical Analysis, vol. 46, no. 3, pp. 557–562, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. X. Yang, W. Ke, P. Zi, F. Liu, and L. Yu, “Detecting and identifying the complexation of nimodipine with hydroxypropyl-β-cyclodextrin present in tablets by Raman spectroscopy,” Journal of Pharmaceutical Sciences, vol. 97, no. 7, pp. 2702–2719, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. F. Belal, A. A. Al-Majed, S. Julkhuf, and N. Y. Khalil, “Spectrofluorometric determination of nimodipine in dosage forms and human urine,” Pharmazie, vol. 58, no. 12, pp. 874–876, 2003. View at Google Scholar · View at Scopus
  12. R. L. Xiong, W. G. Lu, P. Yue et al., “Distribution of an intravenous injectable nimodipine nanosuspension in mice,” Journal of Pharmacy and Pharmacology, vol. 60, no. 9, pp. 1155–1159, 2008. View at Publisher · View at Google Scholar · View at Scopus